Related Experiment Video
Updated: May 26, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
Structural delineation of MDC1-FHA domain binding with CHK2-pThr68
Hsin-Hui Wu1, Pei-Yu Wu, Kai-Fa Huang
1Institute of Biological Chemistry, Academia Sinica, Nankang, Taipei 115, Taiwan.
Abstract:
Mammalian MDC1 interacts with CHK2 in the regulation of DNA damage-induced S-phase checkpoint and apoptosis, which is directed by the association of MDC1-FHA and CHK2-pThr68. However, different ligand specificities of MDC1-FHA have been reported, and no structure is available. Here we report the crystal structures of MDC1-FHA and its complex with a CHK2 peptide containing pThr68. Unlike other FHA domains, MDC1-FHA exists as an intrinsic dimer in solution and in crystals. Structural and binding analyses support pThr+3 ligand specificity and provide structural insight into MDC1-CHK2 interaction.
Insights
The study reveals the crystal structure of Mammalian MDC1-FHA, an intrinsic dimer, and its complex with CHK2 peptide. This provides structural insight into the DNA damage response pathway and MDC1-CHK2 interaction.
Area of Science:
- Molecular Biology
- Structural Biology
- Biochemistry
Background:
- Mammalian MDC1 (Mediator of DNA-damage checkpoint 1) plays a role in DNA damage response.
- MDC1 interacts with CHK2 (Checkpoint Kinase 2) to regulate the S-phase checkpoint and apoptosis.
- This interaction is mediated by the FHA (Forkhead-Associated) domain of MDC1 binding to phosphorylated CHK2 (pThr68), but its structural basis and ligand specificity were unclear.
Purpose of the Study:
- To determine the crystal structure of the MDC1-FHA domain.
- To elucidate the structural basis of the interaction between MDC1-FHA and CHK2-pThr68.
- To investigate the ligand specificity of the MDC1-FHA domain.
Main Methods:
- X-ray crystallography was used to determine the structure of MDC1-FHA alone and in complex with a CHK2 peptide.
- Structural analysis of the obtained crystal structures.
- Binding assays to confirm ligand specificity.
Main Results:
- The crystal structures of MDC1-FHA and its complex with a CHK2 peptide containing pThr68 were determined.
- MDC1-FHA was found to exist as an intrinsic dimer in solution and in crystals, unlike other FHA domains.
- Structural and binding analyses revealed a pThr+3 ligand specificity for MDC1-FHA.
Conclusions:
- The study provides the first structural insights into the MDC1-FHA domain and its interaction with CHK2.
- The dimeric nature of MDC1-FHA is a novel characteristic.
- The findings clarify the molecular mechanism underlying MDC1-CHK2 interaction in the DNA damage response pathway.
Related Concept Videos
Restarting Stalled Replication Forks
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Anaphase Promoting Complex

